PDPL.NS
Price:
$2.9
Market Cap:
$101.08M
Parenteral Drugs (India) Limited operates as a healthcare company in India. The company manufactures pharmaceutical products, including intravenous infusion, inhalation, veterinary infusion, etc. It also offers IV fluids, such as carbohydrates and electrolytes, diuretics, dialysis and irrigation solutions, anti-infective and anti-fungal products, and others; and oncology and anaesthesia products. The company also exports its products to Iraq, Yemen, Mozambique, Ghana, Kenya, Kyrgyzstan, Uzbekistan, Sudan, Vietnam, Cambodia, Liberia, Sri Lanka, Nepal, Myanmar, and Cameroon. The company was incorporated in 1983 and is based in Indore, India.
Industry
Drug Manufacturers - Specialty & Generic
IPO Date
2010-08-19
Stock Exchange
NSE
Ticker
PDPL.NS
According to Parenteral Drugs (India) Ltd.’s latest financial reports and current stock price. The company's current PE Ratio is -0.11. This represents a change of 232.71% compared to the average of -0.03 of the last 4 quarters.
The mean historical PE Ratio of Parenteral Drugs (India) Ltd. over the last ten years is -0.77. The current -0.11 PE Ratio has changed 1.37% with respect to the historical average. Over the past ten years (40 quarters), PDPL.NS's PE Ratio was at its highest in in the June 2013 quarter at 0.97. The PE Ratio was at its lowest in in the December 2014 quarter at -3.21.
Average
-0.77
Median
-0.55
Minimum
-2.32
Maximum
-0.07
Discovering the peaks and valleys of Parenteral Drugs (India) Ltd. PE Ratio, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.
Maximum Annual Increase = 82.16%
Maximum Annual PE Ratio = -0.07
Minimum Annual Increase = -59.79%
Minimum Annual PE Ratio = -2.32
| Year | PE Ratio | Change |
|---|---|---|
| 2022 | -0.14 | 82.16% |
| 2021 | -0.08 | 13.55% |
| 2020 | -0.07 | -58.12% |
| 2019 | -0.16 | -59.79% |
| 2018 | -0.40 | -42.24% |
| 2017 | -0.70 | -31.37% |
| 2016 | -1.02 | 26.26% |
| 2015 | -0.81 | -59.28% |
| 2014 | -1.98 | -14.72% |
| 2013 | -2.32 | -53.23% |
The current PE Ratio of Parenteral Drugs (India) Ltd. (PDPL.NS) is less than than its 3-year, greater than its 5-year, and greater than its 10-year historical averages
3-year avg
-0.10
5-year avg
-0.17
10-year avg
-0.77
Parenteral Drugs (India) Ltd.’s PE Ratio is less than Ganga Pharmaceuticals Limited (119.84), greater than Ortin Laboratories Limited (-2.06), less than Fabino Enterprises Ltd (77.78), less than Bafna Pharmaceuticals Limited (21.39), greater than Vivimed Labs Ltd. (-1.85),
| Company | PE Ratio | Market cap |
|---|---|---|
| 119.84 | $69.05M | |
| -2.06 | $165.31M | |
| 77.78 | $48.30M | |
| 21.39 | $242.50M | |
| -1.85 | $410.42M |
One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like Parenteral Drugs (India) Ltd. using the financials and key metrics that matter to you in a single view.
The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:
Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.
Get your free trial here.
The easiest way to analyze a company like Parenteral Drugs (India) Ltd. or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.
Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.
Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.
What is the PE Ratio?
How can you use the PE Ratio?
What is Parenteral Drugs (India) Ltd.'s PE Ratio?
How is the PE Ratio calculated for Parenteral Drugs (India) Ltd. (PDPL.NS)?
What is the highest PE Ratio for Parenteral Drugs (India) Ltd. (PDPL.NS)?
What is the 3-year average PE Ratio for Parenteral Drugs (India) Ltd. (PDPL.NS)?
What is the 5-year average PE Ratio for Parenteral Drugs (India) Ltd. (PDPL.NS)?
How does the current PE Ratio for Parenteral Drugs (India) Ltd. (PDPL.NS) compare to its historical average?